Evidence map›Paper›PMID 42853951›Full record

ArticleScience advances2026

Cell heterogeneity contributes to the variable response of HIV-1 to latency-reversing agents.

Rachel Topno, Hussein Karaki, Flavia Mazzarda, Oriane Pourcelot, Manon Philippe, Kazem Zibara, Ovidiu Radulescu, Edouard Bertrand

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachel TopnoIGH, University of Montpellier and CNRS, 141 Rue de la Cardonille, Montpellier 34094, France.ORCID 0000-0002-4920-9599
Hussein KarakiIGH, University of Montpellier and CNRS, 141 Rue de la Cardonille, Montpellier 34094, France.
Flavia MazzardaIGH, University of Montpellier and CNRS, 141 Rue de la Cardonille, Montpellier 34094, France.
Oriane PourcelotIGH, University of Montpellier and CNRS, 141 Rue de la Cardonille, Montpellier 34094, France.ORCID 0000-0002-0659-2778
Manon PhilippeIGH, University of Montpellier and CNRS, 141 Rue de la Cardonille, Montpellier 34094, France.ORCID 0009-0009-1039-3024
Kazem ZibaraResearch and Analysis Platform in Environmental Sciences (EDST-PRASE), Lebanese University, Hadath P.O. Box 14-6573, Lebanon.ORCID 0000-0002-9887-072X
Ovidiu RadulescuLPHI, University of Montpellier, CNRS and INSERM, Place Eugene Bataillon, Montpellier 34095, France.ORCID 0000-0001-6453-5707
Edouard BertrandIGH, University of Montpellier and CNRS, 141 Rue de la Cardonille, Montpellier 34094, France.ORCID 0000-0002-9642-7994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcriptional noise contributes to gene expression variability, but its origin and impact in HIV-1 latency remain incompletely characterized. Here, we combine a dual-copy MS2-tagging system with dedicated mathematical analysis to investigate the variability of HIV-1 transcription in live cells. In the basal state, the transcriptional activity of proviruses located in the same cell was uncorrelated, indicating that expression variability primarily comes from the intrinsic stochasticity of promoter dynamics. Upon stimulation with diverse latency-reversing agents, transcription of viral copies became more correlated within cells than across them, revealing a shift from promoter-driven to cell state-driven variability. Analysis of the molecular drug targets confirmed variable effects across cells. Our findings indicate that cellular heterogeneity can shape the response to latency-reversing agents and demonstrate how quantitative tools can dissect noise sources. This work offers mechanistic insights into HIV-1 latency and informs strategies to target the latent viral reservoir.

Indexed as

Anti-HIV AgentsHIV-1HIV InfectionsVirus LatencyGene Expression Regulation, ViralHumansPromoter Regions, GeneticTranscription, GeneticAnti-HIV Agents

Identifiers

PMID42853951
PMCPMC13651875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.